Your Health Plan:
Your Health Plan:
Not SelectedVOSEVI (sofosbuvir, velpatasvir and voxilaprevir) is a brand-name prescription drug for treatment of Cirrhosis. VOSEVI is a combination of hepatitis c virus ns3/4a protease inhibitor, hepatitis c virus ns5a inhibitor and hepatitis c virus nucleotide analog ns5b polymerase inhibitor. It is available in the form of oral tablet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $23100-27000.
Patient Assistance Prorgams and Coupons are found:
No other option is found for VOSEVI